What: Is it DILI? Evaluating Abnormal Liver Function Tests and Identifying Drug Induced Liver Injury (DILI) - Education Meeting
Amber Slevin, PharmD, BCACP
Who: Pharmacists
Where: Webinar/Teleconference
Handout: CPE Instructions - NDSHP Drug Therapy CE Series - 04.09.19.docx
**************************************************************
Methods to join the meeting:
You have been invited to a join.me meeting
Join the meeting: join.me/showmendshp Central Time (US & Canada) In my time zone?
United States - Washington, DC +1.202.602.1295
More phone numbers
Conference ID: 420-684-767 #
Need to share screen? Download the app
Please share with your colleagues that are interested in becoming NDSHP members. This is a great opportunity to "Lunch 'n Learn"!
Fees:
This program is sponsored by the North Dakota Society of Health-System Pharmacists and was initially released December 13, 2016. Attendance at the session and completion of the evaluation form will be required to receive CE credit. Universal activity number: 0047-9999-16-037-L01-P
NDSHP